vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Logistic Properties of the Americas (LPA). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $50.1M, roughly 1.7× Logistic Properties of the Americas). Logistic Properties of the Americas runs the higher net margin — 32.1% vs 6.8%, a 25.3% gap on every dollar of revenue. Logistic Properties of the Americas produced more free cash flow last quarter ($21.4M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Logistic Properties of the Americas is a specialized industrial real estate firm that acquires, develops and manages logistics properties across North, Central and South America. Its portfolio includes distribution centers, warehouses and last-mile delivery facilities, serving e-commerce, retail, manufacturing and third-party logistics clients.
BLLN vs LPA — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $50.1M |
| Net Profit | $5.7M | $16.1M |
| Gross Margin | 69.9% | — |
| Operating Margin | 11.5% | 81.7% |
| Net Margin | 6.8% | 32.1% |
| Revenue YoY | 117.4% | — |
| Net Profit YoY | 138.3% | — |
| EPS (diluted) | $0.10 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $50.1M | ||
| Q3 25 | $83.5M | $32.7M | ||
| Q2 25 | — | $21.5M | ||
| Q1 25 | — | $10.5M | ||
| Q3 24 | $38.4M | $19.2M | ||
| Q1 24 | — | $9.2M |
| Q4 25 | — | $16.1M | ||
| Q3 25 | $5.7M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-14.9M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 69.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | 52.6% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 81.7% | ||
| Q3 25 | 11.5% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | -32.9% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 32.1% | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | -38.8% | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $0.33 | ||
| Q3 25 | $0.10 | $0.09 | ||
| Q2 25 | — | $-0.06 | ||
| Q1 25 | — | — | ||
| Q3 24 | $-1.47 | $-1.26 | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $27.3M |
| Total DebtLower is stronger | $55.0M | $296.8M |
| Stockholders' EquityBook value | $-239.5M | $324.6M |
| Total Assets | $327.5M | $700.8M |
| Debt / EquityLower = less leverage | — | 0.91× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $27.3M | ||
| Q3 25 | $195.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | $1.1M |
| Q4 25 | — | $296.8M | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $324.6M | ||
| Q3 25 | $-239.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | $-242.9M | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $700.8M | ||
| Q3 25 | $327.5M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | 0.91× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $21.6M |
| Free Cash FlowOCF − Capex | $6.5M | $21.4M |
| FCF MarginFCF / Revenue | 7.7% | 42.7% |
| Capex IntensityCapex / Revenue | 8.8% | 0.3% |
| Cash ConversionOCF / Net Profit | 2.42× | 1.34× |
| TTM Free Cash FlowTrailing 4 quarters | — | $12.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $21.6M | ||
| Q3 25 | $13.8M | $14.4M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $4.4M | ||
| Q3 24 | — | $8.3M | ||
| Q1 24 | — | $4.8M |
| Q4 25 | — | $21.4M | ||
| Q3 25 | $6.5M | $-7.3M | ||
| Q2 25 | — | $-3.1M | ||
| Q1 25 | — | $966.4K | ||
| Q3 24 | — | $-2.4M | ||
| Q1 24 | — | $218.9K |
| Q4 25 | — | 42.7% | ||
| Q3 25 | 7.7% | -22.2% | ||
| Q2 25 | — | -14.4% | ||
| Q1 25 | — | 9.2% | ||
| Q3 24 | — | -12.3% | ||
| Q1 24 | — | 2.4% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | 8.8% | 66.1% | ||
| Q2 25 | — | 47.9% | ||
| Q1 25 | — | 32.5% | ||
| Q3 24 | — | 55.5% | ||
| Q1 24 | — | 50.0% |
| Q4 25 | — | 1.34× | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q3 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
LPA
Segment breakdown not available.
